-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.0031% Upside
HOOKIPA Pharma Inc. Frequently Asked Questions
-
What analysts cover HOOKIPA Pharma Inc.?
HOOKIPA Pharma Inc. has been rated by research analysts at Leerink Partners in the past 90 days.